Worried About Teladoc's Post-Pandemic Future? This Statistic Suggests You Shouldn't Be

Worried About Teladoc's Post-Pandemic Future? This Statistic Suggests You Shouldn't Be

The coronavirus pandemic offered Teladoc Health (NYSE: TDOC) a significant boost in 2020. Revenue climbed by triple-digit percentages from quarter to quarter, and its share price surged by 138% for the year. The concern was that Teladoc's business would lose a lot of steam as the pandemic waned and patients could comfortably return to doctors' offices.